https://adisinsight.springer.com/drugsafety/803475405?error=cookies_not_supported&code=0f0b61a0-8f26-4cbf-b856-2f74f9f5125d
Peptide hydrolase-inhibitors/tacrolimus interaction - AdisInsight
A 53-year-old woman and 57-year-old man developed acute kidney injury following the concomitant administration of unspecified protease inhibitor-based regimen
hydrolase inhibitorspeptidetacrolimusinteraction
https://www.techtransfer.nih.gov/patent/e-211-2006-0-ep-05
Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors | Technology Transfer
therapeutic applicationsfatty acidhydrolase inhibitorstechnologytransfer
https://adisinsight.springer.com/drugsafety/803475405?error=cookies_not_supported&code=0f0b61a0-8f26-4cbf-b856-2f74f9f5125d
Peptide hydrolase-inhibitors/tacrolimus interaction - AdisInsight
A 53-year-old woman and 57-year-old man developed acute kidney injury following the concomitant administration of unspecified protease inhibitor-based regimen
hydrolase inhibitorspeptidetacrolimusinteraction
https://oesr.thanhdo.edu.vn/scholar/4114
Searching for potential inhibitors of soluble epoxide hydrolase from xanthone derivatives: an in...
Gout, a prevalent form of inflammatory arthritis, affects individuals of all ages and is increasing worldwide. It is closely associated with hyperuricemia, a...
https://research.unite.it/handle/11575/107687
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?
https://www.techtransfer.nih.gov/patent/e-211-2006-0-ep-05
Therapeutic Applications Of Fatty Acid Amide Hydrolase Inhibitors | Technology Transfer
therapeutic applicationsfatty acidhydrolase inhibitorstechnologytransfer